421 related articles for article (PubMed ID: 27572414)
1. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Sakoulas G; Olson J; Yim J; Singh NB; Kumaraswamy M; Quach DT; Rybak MJ; Pogliano J; Nizet V
Antimicrob Agents Chemother; 2016 Nov; 60(11):6609-6618. PubMed ID: 27572414
[TBL] [Abstract][Full Text] [Related]
2. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Ulloa ER; Singh KV; Geriak M; Haddad F; Murray BE; Nizet V; Sakoulas G
Clin Infect Dis; 2020 Sep; 71(6):1413-1418. PubMed ID: 31773134
[TBL] [Abstract][Full Text] [Related]
3. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
4. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
[TBL] [Abstract][Full Text] [Related]
5. Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin-1 Beta?
Smelter D; Hayney M; Sakoulas G; Rose W
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216621. PubMed ID: 34978891
[TBL] [Abstract][Full Text] [Related]
6. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Tran N; Rybak MJ
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
[TBL] [Abstract][Full Text] [Related]
7. Comparative time-kill study of doxycycline, tigecycline, cefazolin and vancomycin against several clones of Staphylococcus aureus.
Herrera M; Mobilia L; Posse G; Limansky A; Ballerini V; Bantar C
Curr Clin Pharmacol; 2013 Nov; 8(4):332-9. PubMed ID: 23590512
[TBL] [Abstract][Full Text] [Related]
8. Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series.
Cardenas-Alvarez JL; Suarez J; Motoa G; Anjan S; Natori Y; Loebe M; Breda JR; Thakkar-Rivera N; Phancao A; Ghodsizad A; Bauerlein JE; Munagala MR; Simkins J
J Card Surg; 2021 Dec; 36(12):4786-4788. PubMed ID: 34599521
[TBL] [Abstract][Full Text] [Related]
9. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
[TBL] [Abstract][Full Text] [Related]
10. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Li J; Echevarria KL; Traugott KA
Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
[TBL] [Abstract][Full Text] [Related]
12. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
13. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
Trials; 2018 May; 19(1):297. PubMed ID: 29843781
[TBL] [Abstract][Full Text] [Related]
15. Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
Hu Y; Liu A; Vaudrey J; Vaiciunaite B; Moigboi C; McTavish SM; Kearns A; Coates A
PLoS One; 2015; 10(2):e0117664. PubMed ID: 25692771
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.
Hagihara M; Wiskirchen DE; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2012 Jan; 56(1):202-7. PubMed ID: 22006007
[TBL] [Abstract][Full Text] [Related]
17. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.
Hu Y; Coates AR
J Antimicrob Chemother; 2013 Feb; 68(2):374-84. PubMed ID: 23042813
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Wong D; Wong T; Romney M; Leung V
BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
[TBL] [Abstract][Full Text] [Related]
20. Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate.
Hitchins M; O'Mara K; Edwards L; Bouchard J
Pharmacotherapy; 2023 Jan; 43(1):96-99. PubMed ID: 36401791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]